Article

Centricity Vision’s new ZEPTO Plus handpiece gives surgeons a choice in capsulotomy size

CEO Rob Thornhill discusses the features of the device, as well as plans for a new technology called ZEPTOLINK which combines the company’s novel ZEPTO technology with any phaco device.

Video transcript

Note: This transcript has been lightly edited for clarity.

Rob Thornhill: Hello, my name is Rob Thornhill. I'm the CEO of Centricity Vision. We're pleased to announce the introduction of our new ZEPTO Plus handpiece at this year's [American] Academy [of Ophthalmology]. ZEPTO Plus gives our surgeon partners a choice in capsulotomy size when they're working with our automated capsulotomy system.

The ZEPTO Plus creates a 5.4 capsulotomy and allows surgeons to do phaco outside of the capsular bag and also provides a larger capsulotomy for surgeons when they do complex cases. This device provides the same centered, consistent capsulotomies with 360-degree overlap that provides time and cost efficiency in the operating room.

We're also developing a new technology called ZEPTOLINK which combines our ZEPTO technology with any phaco device. This device, when it's completed, will add complete control for the surgeon and the procedure including the capsulotomy through the phaco foot pedal. We are going to the FDA by the end of this year, and we expect if all things go well to be introducing this very exciting new technology by spring 2023.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.